Creon DR 36,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DR26FY5JV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,993
Award facts
- Contract value 100% obligated
- $10,993.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of 36,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement medication. This non-set-aside, competitively awarded contract is valued at $10,993.37 and carries a firm fixed price structure with a completion date of November 21, 2025. The delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of pharmaceutical products, generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The DLA Troop Support Medical is currently planning successor Pharmaceutical Prime Vendor Global Program Generation V contracts with the intent to award multiple vendors for separate regions, demonstrating continued reliance on qualified pharmaceutical distributors to meet federal healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FY5JV?
SPE2DR26FY5JV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FY5JV worth?
The government has obligated $10,993 on SPE2DR26FY5JV.
Is contract SPE2DR26FY5JV an order under another contract?
Yes. SPE2DR26FY5JV is a delivery order under SPE2DR25D1006, an indefinite delivery contract.
Was contract SPE2DR26FY5JV competed?
The extent of competition for SPE2DR26FY5JV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award